Understanding how silica dust affects lung healing and fibrosis
Mechanisms of Impaired Epithelial Regeneration and Fibrosis After Silica Dust Inhalation
This study is looking at how exposure to silica and asbestos affects the healing of lung cells, which could help us find new ways to improve recovery for people with lung diseases like silicosis and asbestosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11127986 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind lung diseases caused by silica and asbestos exposure, specifically focusing on how these substances impair the regeneration of lung epithelial cells. By studying the behavior of alveolar type 2 epithelial cells (AEC2s) in mouse models, the research aims to uncover why these cells fail to properly differentiate and heal after injury, leading to chronic lung fibrosis. The approach includes analyzing the transitional state of AEC2s and their role in the progression of diseases like silicosis and asbestosis. Patients may benefit from insights gained into potential therapeutic targets for improving lung regeneration and reducing fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with silicosis or asbestosis, particularly those experiencing respiratory issues due to these conditions.
Not a fit: Patients with lung diseases unrelated to silica or asbestos exposure may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance lung healing and reduce fibrosis in patients exposed to silica and asbestos.
How similar studies have performed: Previous research has shown promising results in understanding lung regeneration mechanisms, but this specific focus on silica and asbestos-related fibrosis is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zemans, Rachel Lynne — University of Michigan at Ann Arbor
- Study coordinator: Zemans, Rachel Lynne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.